Adriamycin pfs and Caecitis - a phase IV clinical study of FDA data

Summary:

Caecitis is reported as a side effect among people who take Adriamycin pfs (doxorubicin hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Taxotere, and have Breast cancer.

The phase IV clinical study analyzes which people have Caecitis when taking Adriamycin pfs. It is created by eHealthMe based on reports of 6,484 people who have side effects when taking Adriamycin pfs from the FDA, and is updated regularly.

What is Adriamycin pfs?

Adriamycin pfs has active ingredients of doxorubicin hydrochloride. eHealthMe is studying from 6,495 Adriamycin pfs users. Check the latest studies of Adriamycin pfs.

What is Caecitis?

Caecitis (inflammation of the cecum) is found to be associated with 124 drugs and 368 conditions by eHealthMe. Check the latest studies of Caecitis.

On Jul, 20, 2026

6,484 people reported to have side effects when taking Adriamycin pfs.
Among them, 22 people (0.34%) have Caecitis.

Among these 22 people:

How long have people been on Adriamycin pfs when they have Caecitis? *

What is the gender of people who have Caecitis when taking Adriamycin pfs? *

female: 89.47 %
male: 10.53 %

What is the age of people who have Caecitis when taking Adriamycin pfs? *

What are other drugs people take besides Adriamycin pfs? *

What are other side effects people have besides Caecitis? *

Sepsis (a severe blood infection that can lead to organ failure and death): 11 people, 50.00%
Nausea And Vomiting: 8 people, 36.36%
Septic Shock (shock due to blood infection): 8 people, 36.36%
White Blood Cell Count Decreased: 7 people, 31.82%
Nausea (feeling of having an urge to vomit): 7 people, 31.82%
Fever: 6 people, 27.27%
Gastrointestinal Perforation (hole in the digestive tract): 6 people, 27.27%
Abdominal Pain: 6 people, 27.27%
Gastrointestinal Necrosis (destruction of gastrointestinal organ): 5 people, 22.73%
Hypotension (abnormally low blood pressure): 5 people, 22.73%

What are the existing conditions these people have? *

Breast Cancer: 9 people, 40.91%
Stress And Anxiety: 3 people, 13.64%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 13.64%
Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 2 people, 9.09%
Pain: 2 people, 9.09%
Nausea (feeling of having an urge to vomit): 2 people, 9.09%
Ill-Defined Disorder: 2 people, 9.09%
High Blood Pressure: 2 people, 9.09%
Depression: 1 person, 4.55%
Bone Sarcoma (bone cancer): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Adriamycin pfs and have Caecitis?

- Check whether Caecitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Adriamycin pfs:

Adriamycin pfs (6,495 reports)

Caecitis treatments and more:

Caecitis (854 reports)

Browse all side effects of Adriamycin pfs:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Caecitis:

Caecitis (124 drugs)

Browse all the conditions that are associated with Caecitis:

Caecitis (368 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on doxorubicin hydrochloride (the active ingredients of Adriamycin pfs) and Adriamycin pfs (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.